1Brown, A, Pang, E & Roberts, D (1991) Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids 44, 103–106.
2Brown, A, Pang, E & Roberts, D (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 54, 668–673.
3Harris, WS, Sands, SA, Windsor, SL, Ali, HA, Stevens, TL, Magalski, A, Porter, CB & Borkon, AM (2004) Omega-3 fatty acids in cardiac biopsies from heart transplant patients: correlation with erythrocytes and response to supplementation. Circulation 110, 1645–1649.
4Harris, WS & von Schacky, C (2004) The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
5Jeppesen, J, Hein, HO, Suadicani, P & Gyntelberg, F (1998) Triglyceride concentration and ischemic heart disease - an eight-year follow-up in the Copenhagen male study. Circulation 97, 1029–1036.
6Assmann, G, Schulte, H & von Eckardstein, A (1996) Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77, 1179–1184.
7Szapary, PO & Rader, DJ (2004) The triglyceride-high-density lipoprotein axis: an important target of therapy? Am Heart J 148, 211–221.
8Brown, AJ, Roberts, DCK, Pritchard, JE & Truswell, AS (1990) A mixed Australian fish diet and fish-oil supplementation: impact on the plasma lipid profile of healthy men. Am J Clin Nutr 52, 825–833.
9Buckley, R, Shewring, B, Turner, R, Yaqoob, P & Minihane, AM (2004) Circulating triacyglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br J Nutr 92, 477–483.
10Geppert, J, Kraft, V, Demmelmair, H & Koletzko, B (2006) Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial. Br J Nutr 95, 779–786.
11Howe, PRC, Clifton, PM & James, MJ (1999) Equal antithrombotic and triglyceride-lowering effectiveness of eicosapentaenoic acid-rich and docosahexaenoic acid-rich fish oil supplements. Lipids 34, S307–S308.
12Lichtenstein, AH, Applel, LJ, Brands, M, et al. (2006) Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82–96.
13Rambjor, GS, Walen, AI, Windsor, SL & Harris, WS (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31, S45–S49.
14Nestel, P, Shige, H, Pomeroy, S, Cehun, M, Abbey, M & Raederstorff, D (2002) The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 76, 326–330.
15Maki, KC, Van Elswyk, ME, McCarthy, D, Hess, SP, Veith, PE, Bell, M, Subbaiah, P & Davidson, MH (2005) Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J Am Coll Nutr 24, 189–199.
16Schwellenbach, LJ, Olson, KL, McConnell, KJ, Stolcpart, RS, Nash, JD & Merenich, JA (2006) The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr 25, 480–485.
17Harris, WS, Rothrock, DW, Fanning, A, Inkeles, SB, Goodnight, SH Jr, Illingworth, DR & Connor, WE (1990) Fish oils in hypertriglyceridemia: a dose-response study. Am J Clin Nutr 51, 399–406.
18Stacpoole, PW, Alig, J, Ammon, L & Crockett, SE (1989) Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia. Metabolism 38, 946–956.
19Schmidt, EB, Varming, K, Svaneborg, N & Dyerberg, J (1992) N-3 polyunsaturated fatty acid supplementation (pikasol) in men with moderate and severe hypertriglyceridaemia: a dose-response study. Ann Nutr Metab 36, 283–287.
20Davidson, MH, Maki, KC, Kalkowski, J, Schaefer, EJ, Torri, SA & Drennan, KB (1997) Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 16, 236–243.
21Murphy, KJ, Meyer, BJ, Mori, TA, et al. (2007) Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr 97, 749–757.
22Friedewald, W, Levy, R & Fredrickson, S (1972) Estimation of the concentration of low lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
23Park, Y & Harris, WS (2003) Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44, 455–463.
24Davidson, MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, S27–S33.
25Blonk, MC, Bilo, HJ, Nauta, JJ, Popp-Snijders, C, Mulder, C & Donker, AJ (1990) Dose-response effects of fish-oil supplementation in healthy volunteers. Am J Clin Nutr 52, 120–127.
26Nichols, P, Virtue, P, Mooney, B, Elliott, N & Yearsley, G (1998) Seafood the Good Food. Canberra: FRDC.
27Mozaffarian, D & Rimm, EB (2006) Fish intake, contaminants and human health. J Am Med Assoc 296, 1885–1899.
28Mori, TA, Burke, V, Puddey, IB, Watts, GF, O'Neal, DN, Best, JD & Beilin, LJ (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 1085–1094.
29Ross, R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340, 115–126.
30Goodfellow, J, Bellamy, MF, Ramsey, MW, Jones, CJH & Lewis, MJ (2000) Dietary supplementation with marine omega-3 fatty acids improves systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35, 265–270.
31Hill, A, Buckley, J, Murphy, K & Howe, P (2007) Combining fish oil supplementation with regular aerobic exercise improves body composition and cardiovascular risk factors. Am J Clin Nutr 85, 1267–1274.
32Lungershausen, YK, Abbey, M, Nestel, PJ & Howe, PR (1994) Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens 12, 1041–1045.
33Harris, WS (1997) N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, S1645–S1654.
34Sharrett, A, Ballantyne, C, Coady, S, Heiss, G, Sorlie, P, Catellier, D & Patsch, W (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 104, 1108–1113.
35Meyer, BJ, Hammervold, T, Rustan, AC & Howe, PR (2007) Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids 42, 109–115.
36Kelley, DS, Siegel, D, Vemuri, M & Mackey, BE (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 86, 324–333.
37Suzukawa, M, Abbey, M, Howe, PR & Nestel, PJ (1995) Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res 36, 473–484.
38Howe, PR, Downing, JA, Grenyer, BF, Grigonis-Deane, EM & Bryden, WL (2002) Tuna fishmeal as a source of DHA for n-3 PUFA enrichment of pork, chicken and eggs. Lipids 37, 1067–1076.
39Metcalf, R, James, M, Mantzioris, E & Cleland, L (2003) A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats. Eur J Clin Nutr 57, 1605–1612.